MichaelCDuganMD

Anatomic Pathology, Clinical Pathology

Physician

Dr. Dugan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
MCDXI Medical Diagnostics Inc.
3966 Aladdin Dr.
Huntington Beach, CA 92649
Phone+1 805-405-6700

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 1992 - 1994
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1991
University of Arizona College of MedicineClass of 1988

PubMed

53 citations
Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
Sanaa T. Dergham, Michael C. Dugan, Arlauskas P, Wei Du, Vainutis K. Vaitkevicius
International Journal of Pancreatology. 1997-06-01
72 citations
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma
Sanaa T. Dergham, Michael C. Dugan, Roger Kucway, Wei Du, Dalia S. Kamarauskiene
International Journal of Pancreatology. 1997-04-01
51 citations
The clinical significance of p21WAF1/CIP‐1 and p53 expression in pancreatic adenocarcinoma
T B S Sanaa Dergham, Michael C. Dugan, Urwashi S. Joshi, Yong C. Chen, Wei Du
Cancer. 1997-08-01

A New CSF Assay Can Improve Detection and Management of Brain MetastasesSeptember 14th, 2021
Biocept Names Michael Dugan, M.D. Chief Medical Officer and Medical DirectorAugust 24th, 2020
Biocept Names Michael Dugan, M.D. Chief Medical Officer and Medical DirectorAugust 24th, 2020
Join now to see all